Cargando…
Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts
A metabolic phenomenon known as the Warburg effect has been characterized in certain cancerous cells, embryonic stem cells, and other rapidly proliferative cell types. Previously, our attempts to induce a Warburg-like state pharmaceutically via CPI-613 and PS48 treatment did augment metabolite produ...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603033/ https://www.ncbi.nlm.nih.gov/pubmed/31263141 http://dx.doi.org/10.1038/s41598-019-45850-4 |
_version_ | 1783431439393488896 |
---|---|
author | Mordhorst, Bethany R. Kerns, Karl C. Schauflinger, Martin Zigo, Michal Murphy, Stephanie L. Ross, Renee M. Wells, Kevin D. Green, Jonathan A. Sutovsky, Peter Prather, Randall S. |
author_facet | Mordhorst, Bethany R. Kerns, Karl C. Schauflinger, Martin Zigo, Michal Murphy, Stephanie L. Ross, Renee M. Wells, Kevin D. Green, Jonathan A. Sutovsky, Peter Prather, Randall S. |
author_sort | Mordhorst, Bethany R. |
collection | PubMed |
description | A metabolic phenomenon known as the Warburg effect has been characterized in certain cancerous cells, embryonic stem cells, and other rapidly proliferative cell types. Previously, our attempts to induce a Warburg-like state pharmaceutically via CPI-613 and PS48 treatment did augment metabolite production and gene expression; however, this treatment demonstrated a Reverse Warburg effect phenotype observed in cancer-associated stroma. In the current study, we inquired whether the mitochondria were affected by the aforementioned pharmaceutical treatment as observed in cancerous stromal fibroblasts. While the pharmaceutical agents decreased mitochondrial membrane potential in porcine fetal fibroblasts, the number and size of mitochondria were similar, as was the overall cell size. Moreover, the fibroblasts that were treated with CPI-613 and PS48 for a week had increased numbers of large autolysosome vesicles. This coincided with increased intensity of LysoTracker staining in treated cells as observed by flow cytometry. Treated fibroblasts thus may utilize changes in metabolism and autophagy to mitigate the damage of treatment with pharmaceutical agents. These findings shed light on how these pharmaceutical agents interact and how treated cells augment metabolism to sustain viability. |
format | Online Article Text |
id | pubmed-6603033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-66030332019-07-14 Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts Mordhorst, Bethany R. Kerns, Karl C. Schauflinger, Martin Zigo, Michal Murphy, Stephanie L. Ross, Renee M. Wells, Kevin D. Green, Jonathan A. Sutovsky, Peter Prather, Randall S. Sci Rep Article A metabolic phenomenon known as the Warburg effect has been characterized in certain cancerous cells, embryonic stem cells, and other rapidly proliferative cell types. Previously, our attempts to induce a Warburg-like state pharmaceutically via CPI-613 and PS48 treatment did augment metabolite production and gene expression; however, this treatment demonstrated a Reverse Warburg effect phenotype observed in cancer-associated stroma. In the current study, we inquired whether the mitochondria were affected by the aforementioned pharmaceutical treatment as observed in cancerous stromal fibroblasts. While the pharmaceutical agents decreased mitochondrial membrane potential in porcine fetal fibroblasts, the number and size of mitochondria were similar, as was the overall cell size. Moreover, the fibroblasts that were treated with CPI-613 and PS48 for a week had increased numbers of large autolysosome vesicles. This coincided with increased intensity of LysoTracker staining in treated cells as observed by flow cytometry. Treated fibroblasts thus may utilize changes in metabolism and autophagy to mitigate the damage of treatment with pharmaceutical agents. These findings shed light on how these pharmaceutical agents interact and how treated cells augment metabolism to sustain viability. Nature Publishing Group UK 2019-07-01 /pmc/articles/PMC6603033/ /pubmed/31263141 http://dx.doi.org/10.1038/s41598-019-45850-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Mordhorst, Bethany R. Kerns, Karl C. Schauflinger, Martin Zigo, Michal Murphy, Stephanie L. Ross, Renee M. Wells, Kevin D. Green, Jonathan A. Sutovsky, Peter Prather, Randall S. Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
title | Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
title_full | Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
title_fullStr | Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
title_full_unstemmed | Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
title_short | Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
title_sort | pharmacologic treatment with cpi-613 and ps48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603033/ https://www.ncbi.nlm.nih.gov/pubmed/31263141 http://dx.doi.org/10.1038/s41598-019-45850-4 |
work_keys_str_mv | AT mordhorstbethanyr pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT kernskarlc pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT schauflingermartin pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT zigomichal pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT murphystephaniel pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT rossreneem pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT wellskevind pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT greenjonathana pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT sutovskypeter pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts AT pratherrandalls pharmacologictreatmentwithcpi613andps48decreasesmitochondrialmembranepotentialandincreasesquantityofautolysosomesinporcinefibroblasts |